Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
75%(6 trials)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_1
1
10%
Ph phase_4
5
50%
Ph phase_3
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(8)
Other(2)

Detailed Status

Completed8
unknown2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 31 (11.1%)
Phase 45 (55.6%)
N/A2 (22.2%)

Trials by Status

unknown220%
completed880%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10